Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT-Reference-Cited by-同舟云学术

Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

Published:2024-03-19 Issue:7 Volume:59 Page:950-956
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Guièze Romain^ORCID,Eikema Diderik-Jan,Koster Linda,Schetelig Johannes^ORCID,Sengeloev Henrik,Passweg Jakob^ORCID,Finke Jürgen^ORCID,Arat Mutlu^ORCID,Broers Annoek E. C.,Stölzel Friedrich^ORCID,Byrne Jenny,Castilla-Llorente Cristina,Dreger Peter^ORCID,Eder Matthias,Gedde-Dahl Tobias,Kröger Nicolaus^ORCID,Ribera Santasusana Josep Maria^ORCID,Richardson Deborah^ORCID,Rambaldi Alessandro,Yañez Lucrecia,Van Gelder Michel,Drozd-Sokolowska Joanna^ORCID,Raj Kavita^ORCID,Yakoub-Agha Ibrahim^ORCID,Tournilhac Olivier^ORCID,McLornan Donal P.^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41409-024-02256-9.pdf

Reference29 articles.

1. Parikh SA, Kay NE, Shanafelt TD. How we treat Richter syndrome. Blood. 2014;123:1647–57.

2. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.

3. Thompson PA, Siddiqi T. Treatment of Richter’s syndrome. Hematology. 2022;2022:329–36.

4. Burger JA, Tedeschi A, Barr PM, Robak T, Owen C, Ghia P, et al. Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia. NEJM. 2015;373:2425–37.

5. Byrd JC, Brown JR, O’Brien S, Barrientos JC, Kay NE, Reddy NM, et al. Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. NEJM. 2014;371:213–23.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming the unmet need of Richter transformation: the use of pirtobrutinib;The Lancet Haematology;2024-09